Insulin detemir: a long-acting insulin analog for the treatment of Type 1 and 2 diabetes

By Meneghini Luigi F  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 513-529

Future Medicine

Access to resources Recommend Favorite

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

By Seino Yutaka   Nakajima Hiromu   Miyahara Hajime   Kurita Takashi   Bush Mark A.   Yang Fred   Stewart Murray W.    

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3049-3057

Informa Healthcare

Access to resources Recommend Favorite

Positive effects of GLP‐1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 3, 2015-03 ,pp. : 248-255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacological characterization and antidiabetic activity of a long‐acting glucagon‐like peptide‐1 analogue conjugated to an antithrombin III‐binding pentasaccharide

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 8, 2015-08 ,pp. : 760-770

John Wiley & Sons Inc

Access to resources Recommend Favorite

Depression, metabolic control, and antidepressant medication in young patients with type 1 diabetes

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 1, 2015-02 ,pp. : 58-66

John Wiley & Sons Inc

Access to resources Recommend Favorite